These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Author: Nakata H, Matsuzaki M, Shimamoto Y, Yamaguchi M.
    Journal: Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069.
    Abstract:
    Recombinant human erythropoietin was administered to an anemic patient with multiple myeloma (IgD, lambda type) and renal dysfunction who had been dependent on blood transfusions. Three thousand units of the recombinant human erythropoietin was given intravenously three times a week. Thereafter transfusion requirements, hemoglobin level, and reticulocyte responses have been monitored. An increase in hemoglobin level and reticulocyte counts was observed within 10 days and then further blood transfusion was not necessary. Neither organ dysfunction nor toxic effects were observed. The administration of recombinant human erythropoietin can be a new method to treat anemia associated with multiple myeloma and renal dysfunction.
    [Abstract] [Full Text] [Related] [New Search]